nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—Cardiac fibrillation—Lisinopril—dilated cardiomyopathy	0.0313	0.0392	CcSEcCtD
Levobupivacaine—Hypotensive—Furosemide—dilated cardiomyopathy	0.0298	0.0374	CcSEcCtD
Levobupivacaine—SCN4A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0237	0.209	CbGpPWpGaD
Levobupivacaine—Breast pain—Spironolactone—dilated cardiomyopathy	0.0229	0.0288	CcSEcCtD
Levobupivacaine—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0228	0.201	CbGpPWpGaD
Levobupivacaine—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0197	0.0247	CcSEcCtD
Levobupivacaine—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.0189	0.0237	CcSEcCtD
Levobupivacaine—Ranolazine—SCN5A—dilated cardiomyopathy	0.0188	0.212	CrCbGaD
Levobupivacaine—Mepivacaine—SCN5A—dilated cardiomyopathy	0.0188	0.212	CrCbGaD
Levobupivacaine—Ropivacaine—SCN5A—dilated cardiomyopathy	0.0149	0.167	CrCbGaD
Levobupivacaine—Lethargy—Spironolactone—dilated cardiomyopathy	0.0148	0.0186	CcSEcCtD
Levobupivacaine—Tocainide—SCN5A—dilated cardiomyopathy	0.014	0.157	CrCbGaD
Levobupivacaine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0127	0.016	CcSEcCtD
Levobupivacaine—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0119	0.0149	CcSEcCtD
Levobupivacaine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0112	0.014	CcSEcCtD
Levobupivacaine—Lidocaine—SCN5A—dilated cardiomyopathy	0.0108	0.122	CrCbGaD
Levobupivacaine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.0107	0.0134	CcSEcCtD
Levobupivacaine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00974	0.0122	CcSEcCtD
Levobupivacaine—Breast pain—Lisinopril—dilated cardiomyopathy	0.00936	0.0117	CcSEcCtD
Levobupivacaine—SCN4A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00908	0.0801	CbGpPWpGaD
Levobupivacaine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00904	0.0113	CcSEcCtD
Levobupivacaine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00884	0.0111	CcSEcCtD
Levobupivacaine—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00876	0.0772	CbGpPWpGaD
Levobupivacaine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00869	0.0109	CcSEcCtD
Levobupivacaine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00841	0.0105	CcSEcCtD
Levobupivacaine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00827	0.0104	CcSEcCtD
Levobupivacaine—Purpura—Furosemide—dilated cardiomyopathy	0.0082	0.0103	CcSEcCtD
Levobupivacaine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00817	0.0102	CcSEcCtD
Levobupivacaine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00817	0.0102	CcSEcCtD
Levobupivacaine—Lethargy—Furosemide—dilated cardiomyopathy	0.00807	0.0101	CcSEcCtD
Levobupivacaine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00803	0.0101	CcSEcCtD
Levobupivacaine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00767	0.00962	CcSEcCtD
Levobupivacaine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00752	0.00942	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.0074	0.00928	CcSEcCtD
Levobupivacaine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00731	0.00916	CcSEcCtD
Levobupivacaine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00727	0.00912	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00722	0.00905	CcSEcCtD
Levobupivacaine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0072	0.00903	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00714	0.00895	CcSEcCtD
Levobupivacaine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00697	0.00874	CcSEcCtD
Levobupivacaine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00688	0.00862	CcSEcCtD
Levobupivacaine—Injury—Lisinopril—dilated cardiomyopathy	0.00645	0.00809	CcSEcCtD
Levobupivacaine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00635	0.00796	CcSEcCtD
Levobupivacaine—Lidocaine—SLC22A5—dilated cardiomyopathy	0.00623	0.07	CrCbGaD
Levobupivacaine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00616	0.00773	CcSEcCtD
Levobupivacaine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00613	0.00768	CcSEcCtD
Levobupivacaine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00609	0.00764	CcSEcCtD
Levobupivacaine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00593	0.00744	CcSEcCtD
Levobupivacaine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00593	0.00744	CcSEcCtD
Levobupivacaine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00588	0.00738	CcSEcCtD
Levobupivacaine—Sweating—Furosemide—dilated cardiomyopathy	0.00584	0.00732	CcSEcCtD
Levobupivacaine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00567	0.00711	CcSEcCtD
Levobupivacaine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00564	0.00708	CcSEcCtD
Levobupivacaine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00564	0.00707	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00556	0.00697	CcSEcCtD
Levobupivacaine—Lidocaine—EGFR—dilated cardiomyopathy	0.00543	0.0609	CrCbGaD
Levobupivacaine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00542	0.00679	CcSEcCtD
Levobupivacaine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00526	0.0066	CcSEcCtD
Levobupivacaine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0051	0.00639	CcSEcCtD
Levobupivacaine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00505	0.00633	CcSEcCtD
Levobupivacaine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00504	0.00632	CcSEcCtD
Levobupivacaine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00499	0.00626	CcSEcCtD
Levobupivacaine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00489	0.00613	CcSEcCtD
Levobupivacaine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00488	0.00612	CcSEcCtD
Levobupivacaine—Erythema—Furosemide—dilated cardiomyopathy	0.00476	0.00597	CcSEcCtD
Levobupivacaine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00476	0.00597	CcSEcCtD
Levobupivacaine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00472	0.00592	CcSEcCtD
Levobupivacaine—Flatulence—Furosemide—dilated cardiomyopathy	0.00469	0.00588	CcSEcCtD
Levobupivacaine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00458	0.00574	CcSEcCtD
Levobupivacaine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00454	0.00569	CcSEcCtD
Levobupivacaine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00449	0.00562	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00448	0.00562	CcSEcCtD
Levobupivacaine—Headache—Spironolactone—dilated cardiomyopathy	0.00447	0.00561	CcSEcCtD
Levobupivacaine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00444	0.00557	CcSEcCtD
Levobupivacaine—Anaemia—Furosemide—dilated cardiomyopathy	0.0044	0.00552	CcSEcCtD
Levobupivacaine—Sweating—Lisinopril—dilated cardiomyopathy	0.00438	0.00549	CcSEcCtD
Levobupivacaine—Agitation—Furosemide—dilated cardiomyopathy	0.00437	0.00548	CcSEcCtD
Levobupivacaine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00436	0.00546	CcSEcCtD
Levobupivacaine—Nausea—Spironolactone—dilated cardiomyopathy	0.00424	0.00532	CcSEcCtD
Levobupivacaine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00418	0.00524	CcSEcCtD
Levobupivacaine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00404	0.00507	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00402	0.00505	CcSEcCtD
Levobupivacaine—Confusional state—Furosemide—dilated cardiomyopathy	0.00392	0.00491	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00388	0.00487	CcSEcCtD
Levobupivacaine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00382	0.0048	CcSEcCtD
Levobupivacaine—Shock—Furosemide—dilated cardiomyopathy	0.00382	0.00479	CcSEcCtD
Levobupivacaine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00381	0.00478	CcSEcCtD
Levobupivacaine—Flushing—Lisinopril—dilated cardiomyopathy	0.00381	0.00477	CcSEcCtD
Levobupivacaine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00377	0.00473	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00376	0.00471	CcSEcCtD
Levobupivacaine—Chills—Lisinopril—dilated cardiomyopathy	0.00368	0.00462	CcSEcCtD
Levobupivacaine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00366	0.0046	CcSEcCtD
Levobupivacaine—Hypotension—Furosemide—dilated cardiomyopathy	0.00363	0.00455	CcSEcCtD
Levobupivacaine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00359	0.00451	CcSEcCtD
Levobupivacaine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00357	0.00448	CcSEcCtD
Levobupivacaine—Erythema—Lisinopril—dilated cardiomyopathy	0.00357	0.00448	CcSEcCtD
Levobupivacaine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00352	0.00441	CcSEcCtD
Levobupivacaine—Tension—Lisinopril—dilated cardiomyopathy	0.0035	0.00439	CcSEcCtD
Levobupivacaine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00349	0.00437	CcSEcCtD
Levobupivacaine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00347	0.00435	CcSEcCtD
Levobupivacaine—Back pain—Lisinopril—dilated cardiomyopathy	0.00345	0.00433	CcSEcCtD
Levobupivacaine—Somnolence—Furosemide—dilated cardiomyopathy	0.00345	0.00433	CcSEcCtD
Levobupivacaine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00343	0.0043	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00343	0.0303	CbGpPWpGaD
Levobupivacaine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00338	0.00423	CcSEcCtD
Levobupivacaine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00337	0.00422	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00335	0.0042	CcSEcCtD
Levobupivacaine—Tremor—Lisinopril—dilated cardiomyopathy	0.00335	0.0042	CcSEcCtD
Levobupivacaine—Pain—Furosemide—dilated cardiomyopathy	0.00332	0.00416	CcSEcCtD
Levobupivacaine—Constipation—Furosemide—dilated cardiomyopathy	0.00332	0.00416	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00331	0.0292	CbGpPWpGaD
Levobupivacaine—Anaemia—Lisinopril—dilated cardiomyopathy	0.0033	0.00414	CcSEcCtD
Levobupivacaine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00326	0.00409	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00323	0.0285	CbGpPWpGaD
Levobupivacaine—Syncope—Lisinopril—dilated cardiomyopathy	0.0032	0.00402	CcSEcCtD
Levobupivacaine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0032	0.00401	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00318	0.00398	CcSEcCtD
Levobupivacaine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00316	0.00396	CcSEcCtD
Levobupivacaine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00314	0.00394	CcSEcCtD
Levobupivacaine—Cough—Lisinopril—dilated cardiomyopathy	0.00312	0.00391	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00312	0.0275	CbGpPWpGaD
Levobupivacaine—Urticaria—Furosemide—dilated cardiomyopathy	0.00309	0.00387	CcSEcCtD
Levobupivacaine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00307	0.00385	CcSEcCtD
Levobupivacaine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00307	0.00385	CcSEcCtD
Levobupivacaine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00304	0.00381	CcSEcCtD
Levobupivacaine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00303	0.0038	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00302	0.00379	CcSEcCtD
Levobupivacaine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00294	0.00368	CcSEcCtD
Levobupivacaine—Oedema—Lisinopril—dilated cardiomyopathy	0.00291	0.00365	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00291	0.00365	CcSEcCtD
Levobupivacaine—Infection—Lisinopril—dilated cardiomyopathy	0.0029	0.00363	CcSEcCtD
Levobupivacaine—Shock—Lisinopril—dilated cardiomyopathy	0.00287	0.0036	CcSEcCtD
Levobupivacaine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00286	0.00359	CcSEcCtD
Levobupivacaine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00284	0.00357	CcSEcCtD
Levobupivacaine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00283	0.00355	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00282	0.00353	CcSEcCtD
Levobupivacaine—Asthenia—Furosemide—dilated cardiomyopathy	0.00279	0.00349	CcSEcCtD
Levobupivacaine—Pruritus—Furosemide—dilated cardiomyopathy	0.00275	0.00345	CcSEcCtD
Levobupivacaine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00272	0.00341	CcSEcCtD
Levobupivacaine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00266	0.00333	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00266	0.00333	CcSEcCtD
Levobupivacaine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00264	0.00331	CcSEcCtD
Levobupivacaine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00262	0.00328	CcSEcCtD
Levobupivacaine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0026	0.00326	CcSEcCtD
Levobupivacaine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00259	0.00325	CcSEcCtD
Levobupivacaine—Dizziness—Furosemide—dilated cardiomyopathy	0.00257	0.00322	CcSEcCtD
Levobupivacaine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00257	0.00322	CcSEcCtD
Levobupivacaine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00253	0.00318	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00252	0.00315	CcSEcCtD
Levobupivacaine—Pain—Lisinopril—dilated cardiomyopathy	0.00249	0.00313	CcSEcCtD
Levobupivacaine—Constipation—Lisinopril—dilated cardiomyopathy	0.00249	0.00313	CcSEcCtD
Levobupivacaine—Vomiting—Furosemide—dilated cardiomyopathy	0.00247	0.0031	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00245	0.0216	CbGpPWpGaD
Levobupivacaine—Headache—Furosemide—dilated cardiomyopathy	0.00243	0.00305	CcSEcCtD
Levobupivacaine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0024	0.00301	CcSEcCtD
Levobupivacaine—SCN4A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.0024	0.0211	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00238	0.00299	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00236	0.0208	CbGpPWpGaD
Levobupivacaine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00232	0.0029	CcSEcCtD
Levobupivacaine—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00231	0.0204	CbGpPWpGaD
Levobupivacaine—Nausea—Furosemide—dilated cardiomyopathy	0.00231	0.00289	CcSEcCtD
Levobupivacaine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.0023	0.00289	CcSEcCtD
Levobupivacaine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.0023	0.00289	CcSEcCtD
Levobupivacaine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00215	0.00269	CcSEcCtD
Levobupivacaine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00209	0.00262	CcSEcCtD
Levobupivacaine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00206	0.00259	CcSEcCtD
Levobupivacaine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00199	0.0025	CcSEcCtD
Levobupivacaine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00193	0.00242	CcSEcCtD
Levobupivacaine—SCN4A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00193	0.017	CbGpPWpGaD
Levobupivacaine—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00186	0.0164	CbGpPWpGaD
Levobupivacaine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00185	0.00232	CcSEcCtD
Levobupivacaine—Headache—Lisinopril—dilated cardiomyopathy	0.00183	0.00229	CcSEcCtD
Levobupivacaine—Nausea—Lisinopril—dilated cardiomyopathy	0.00173	0.00217	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00145	0.0128	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00143	0.0126	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.0014	0.0123	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00103	0.00911	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000996	0.00878	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000905	0.00798	CbGpPWpGaD
Levobupivacaine—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000875	0.00772	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000873	0.0077	CbGpPWpGaD
Levobupivacaine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000844	0.00745	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	0.000728	0.00642	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000702	0.00619	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000658	0.00581	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000646	0.0057	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000632	0.00558	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000623	0.00549	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	0.000551	0.00486	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	0.000531	0.00469	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000519	0.00458	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000501	0.00442	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	0.000482	0.00426	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	0.000465	0.0041	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000411	0.00363	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000391	0.00345	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000368	0.00324	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	0.000344	0.00304	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	0.000332	0.00293	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	0.000331	0.00292	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	0.000319	0.00281	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000282	0.00249	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000282	0.00249	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000269	0.00237	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000269	0.00237	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	0.000236	0.00208	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	0.000228	0.00201	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	0.000225	0.00198	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	0.000217	0.00191	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000174	0.00154	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000164	0.00144	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000148	0.00131	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000134	0.00119	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000126	0.00112	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000114	0.00101	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.04e-05	0.000797	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.8e-05	0.000776	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.92e-05	0.000699	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.02e-05	0.000355	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.92e-05	0.000346	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.53e-05	0.000311	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.11e-05	0.000274	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.02e-05	0.000267	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.72e-05	0.00024	CbGpPWpGaD
